Public Consultation Meeting of the Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight, 71654-71655 [E8-28013]

Download as PDF 71654 Federal Register / Vol. 73, No. 228 / Tuesday, November 25, 2008 / Notices managers, General Accountability Office, and Federal agency Inspector General Offices. The panel is particularly interested in stakeholder views as to how the issues discussed above may relate differently to the purchase of goods, services, or goods and services that are configured to propose an integrated solution to an agency’s needs. Written comments may be submitted at any time in accordance with the guidance below. The meeting will be held at U.S. General Services Administration, Federal Acquisition Service, 2200 Crystal Drive, Room L1301, Arlington, VA 22202. The location is within walking distance of the Crystal City metro stop. The meeting start time is 9:00 a.m., and will adjourn no later than 5:00 p.m. For presentations before the Panel, the following guidance is provided: Oral comments: The Panel will no longer entertain oral presentations. Written Comments: Written comments must be received ten (10) business days prior to the meeting date so that the comments may be provided to the Panel for their consideration prior to the meeting. Comments should be supplied to Ms. Brooks at the address/contact information noted below in the following format: one hard copy with original signature and one electronic copy via email in Microsoft Word. Subsequent meeting dates, locations, and times will be published at least 15 days prior to the meeting date. FOR FURTHER INFORMATION CONTACT: Information on the Panel meetings, agendas, and other information can be obtained at www.gsa.gov/ masadvisorypanel or you may contact Ms. Pat Brooks, Designated Federal Officer, Multiple Award Schedule Advisory Panel, U.S. General Services Administration, 2011 Crystal Drive, Suite 911, Arlington, VA 22205; telephone 703 605–3406, Fax 703 605– 3454; or via email at mas.advisorypanel@gsa.gov. jlentini on PROD1PC65 with NOTICES AVAILABILITY OF MATERIALS: All meeting materials, including meeting agendas, handouts, public comments, and meeting minutes will be posted on the MAS Panel website at www.gsa.gov/ masadvisorypanel or www.gsa.gov/ masap. MEETING ACCESS: Individuals requiring special accommodations at any of these meetings should contact Ms. Brooks at least ten (10) business days prior to the meeting date so that appropriate arrangements can be made. VerDate Aug<31>2005 17:01 Nov 24, 2008 Jkt 217001 Dated: November 19, 2008 David A. Drabkin, Deputy Chief Acquisition Officer, Office of the Chief Acquisition Officer, General Services Administration. [FR Doc. E8–27951 Filed 11–24–08; 8:45 am] BILLING CODE 6820–EP–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Consultation Meeting of the Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight Department of Health and Human Services, Office of the Secretary. ACTION: Notice. AGENCY: SUMMARY: The U.S. Department of Health and Human Services is hereby giving notice that the Trans-Federal Task Force on Biosafety and Biocontainment Oversight will be holding a public consultation meeting. The meeting is open to the public. DATES: The Trans-Federal Task Force on Biosafety and Biocontainment Oversight will hold a public consultation meeting on December 8, 2008 from 8:30 a.m. to 5 p.m. EST and December 9, 2008 from 8:30 a.m. to 2:45 p.m. EST. ADDRESSES: The Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Phone: 301–822–9200. FOR FURTHER INFORMATION CONTACT: CAPT Theresa Lawrence, Ph.D., Office of Medicine, Science and Public Health, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, 330 C Street, SW., Room 5008C, Washington, DC 20447; phone: 202–401–5879; fax: 202–205–8494; email address: biosafetytaskforce@hhs.gov. The Federal government established the Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight to undertake an intensive analysis of the current framework of biosafety and biocontainment oversight of research activities involving infectious agents and toxins in high- and maximumcontainment research facilities. The Task Force envisions effective comprehensive local and Federal oversight that protects laboratory workers, public health, agriculture, and the environment while fostering progress in life sciences research. The Task Force is chaired by officials from the U.S. Department of Health and Human Services and the U.S. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Department of Agriculture and is comprised of representatives from a broad range of Federal departments and agencies that have responsibility for, and oversight of, the management of biohazard risks. Background: The Task Force’s purpose is to ‘‘explore methods to improve biosafety oversight in the United States to include a review of mechanisms by which the Federal Government can ensure safe working conditions in laboratories handling infectious agents.’’ This public consultation meeting will allow the Task Force to obtain individual input from members of the public on several aspects of biosafety and biocontainment oversight in the U.S. The meeting’s dialogue will focus on a series of questions on which the U.S. Government would specifically like to solicit comment. These questions concern such matters as the identification of gaps in the current oversight framework and options for improvement, including how to optimize biosafety and biocontainment oversight while simultaneously protecting laboratory workers, public health, agriculture, and the environment. The agenda and questions for discussion will be available prior to the meeting at the Web site http:// www.hhs.gov/aspr/omsph/ biosafetytaskforce/index.html. All public comments and recommendations will be considered by the Task Force. Availability of Materials: The agenda and other materials will be posted on the Task Force’s Web site at http:// www.hhs.gov/aspr/omsph/ biosafetytaskforce/index.html prior to the meeting. Procedures for Providing Public Input: Public participation in this meeting of the Task Force is encouraged. Interested members of the public may attend the meeting in person or participate by public teleconference. Any member of the public wishing to obtain information regarding participation by teleconference should consult the Web site: http://www.hhs.gov/aspr/omsph/ biosafetytaskforce/index.html or contact CAPT Theresa Lawrence (preferably by e-mail) for more information. Interested members of the public may submit relevant written or oral information for the Task Force to consider. Oral and written information that is submitted may be made be available to the public; therefore, we request that statements do not include private or proprietary information. Oral Statements: Thirty minutes will be available each day of the meeting for public comment. In general, each speaker (or group of speakers) requesting an oral E:\FR\FM\25NON1.SGM 25NON1 Federal Register / Vol. 73, No. 228 / Tuesday, November 25, 2008 / Notices presentation will be limited to three minutes. To be placed on the public speaker list, interested parties should contact CAPT Theresa Lawrence in writing (preferably via e-mail), by November 28, 2008. Written Statements: In general, individuals or groups may file written comments with the Task Force. All written comments must be received prior to December 12, 2008 and should be sent to CAPT Theresa Lawrence (preferably by e-mail with ‘‘Task Force Public Comment’’ as the subject line). Individuals needing special assistance should notify CAPT Theresa Lawrence (preferably by e-mail) by November 28, 2008. Dated:November 18, 2008. RADM William C. Vanderwagen, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services. [FR Doc. E8–28013 Filed 11–24–08; 8:45 am] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–D–0588] Compliance Policy Guide Sec. 540.700 Processed and/or Blended Seafood Products (CPG 7108.16); Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of revised Compliance Policy Guide Sec. 540.700 Processed and/or Blended Seafood Products (CPG 7108.16) (the CPG). The CPG provides guidance for FDA staff on FDA’s labeling requirements for processed and blended seafood products. DATES: Submit written or electronic comments regarding the CPG at any time. Submit written comments on the CPG to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to http:// www.regulations.gov. Submit written requests for single copies of the CPG to the Division of Compliance Policy (HFC–230), Office of Enforcement, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857. Send two self-addressed adhesive labels to assist that office in processing your request, or fax your request to 240–632–6861. See jlentini on PROD1PC65 with NOTICES ADDRESSES: VerDate Aug<31>2005 17:01 Nov 24, 2008 Jkt 217001 the SUPPLEMENTARY INFORMATION section for electronic access to the CPG. FOR FURTHER INFORMATION CONTACT: Catalina Ferre-Hockensmith, Center for Food Safety and Applied Nutrition (HFS–820), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301– 436–2371. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of July 26, 1985 (50 FR 30523), FDA made available Compliance Policy Guide 7108.16, which was subsequently renumbered and renamed Compliance Policy Guide Sec. 540.700 Processed and/or Blended Seafood Products (CPG 7108.16). FDA has revised the CPG. The CPG provides guidance for FDA staff on FDA’s labeling requirements for processed and blended seafood products. The CPG also contains information that may be useful to the regulated industry and to the public. FDA is issuing the revisions to the CPG as Level 2 guidance under FDA’s good guidance practices regulation (21 CFR 10.115). Consistent with FDA’s good guidance practices regulation, the agency will accept comments on the CPG at any time. The CPG represents the agency’s current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternate approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. II. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) written or electronic comments regarding the document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at http://www.regulations.gov. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 71655 III. Electronic Access Persons with access to the Internet may obtain the CPG from FDA’s Office of Regulatory Affairs history page. It may be accessed at http://www.fda.gov/ ora/compliance_ref/cpg/cpgfod/cpg540700.html. Dated: November 14, 2008. Michael A. Chappell, Acting Associate Commissioner for Regulatory Affairs. [FR Doc. E8–27969 Filed 11–24–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HOMELAND SECURITY Welcome to the DHS Enterprise eRecruitment System Office of the Chief Human Capital Officer, DHS. ACTION: 60-Day Notice and request for comments; Information Collection submission for OMB Review. AGENCY: SUMMARY: The Department of Homeland Security, Office of the Chief Human Capital Officer has submitted the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. Chapter 35). DATES: Comments are encouraged and will be accepted until January 26, 2009. This process is conducted in accordance with 5 CFR 1320.1. ADDRESSES: Comments and questions about this Information Collection Request should be forwarded to the Office of the Chief Human Capital Officer, Attn: Mabeline Hall for the Department of Homeland Security/ CHCO, 245 Murray Lane SW., Building 410, Washington, DC 20528. FOR FURTHER INFORMATION CONTACT: Mabeline Hall, 202–357–8272 (this is not a toll free number). SUPPLEMENTARY INFORMATION: The Department of Homeland Security (DHS), Office of the Chief Human Capital Officer (OCHCO) is implementing an enterprise eRecruitment system for DHS. The use of an automated recruitment solution is necessary to meet mission critical needs of DHS and comply with the 45-day hiring model under the President’s Management Agenda. Technology-enabled recruitment can deliver both time savings and improved results. Based on an internal inventory of DHS human resource (HR) systems, more than 50 systems are currently used E:\FR\FM\25NON1.SGM 25NON1

Agencies

[Federal Register Volume 73, Number 228 (Tuesday, November 25, 2008)]
[Notices]
[Pages 71654-71655]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-28013]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Consultation Meeting of the Trans-Federal Task Force on 
Optimizing Biosafety and Biocontainment Oversight

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of Health and Human Services is hereby 
giving notice that the Trans-Federal Task Force on Biosafety and 
Biocontainment Oversight will be holding a public consultation meeting. 
The meeting is open to the public.

DATES: The Trans-Federal Task Force on Biosafety and Biocontainment 
Oversight will hold a public consultation meeting on December 8, 2008 
from 8:30 a.m. to 5 p.m. EST and December 9, 2008 from 8:30 a.m. to 
2:45 p.m. EST.

ADDRESSES: The Bethesda North Marriott Hotel and Conference Center, 
5701 Marinelli Road, North Bethesda, MD 20852. Phone: 301-822-9200.

FOR FURTHER INFORMATION CONTACT: CAPT Theresa Lawrence, Ph.D., Office 
of Medicine, Science and Public Health, Office of the Assistant 
Secretary for Preparedness and Response, U.S. Department of Health and 
Human Services, 330 C Street, SW., Room 5008C, Washington, DC 20447; 
phone: 202-401-5879; fax: 202-205-8494; e-mail address: 
biosafetytaskforce@hhs.gov.

SUPPLEMENTARY INFORMATION: The Federal government established the 
Trans-Federal Task Force on Optimizing Biosafety and Biocontainment 
Oversight to undertake an intensive analysis of the current framework 
of biosafety and biocontainment oversight of research activities 
involving infectious agents and toxins in high- and maximum-containment 
research facilities. The Task Force envisions effective comprehensive 
local and Federal oversight that protects laboratory workers, public 
health, agriculture, and the environment while fostering progress in 
life sciences research. The Task Force is chaired by officials from the 
U.S. Department of Health and Human Services and the U.S. Department of 
Agriculture and is comprised of representatives from a broad range of 
Federal departments and agencies that have responsibility for, and 
oversight of, the management of biohazard risks.
    Background: The Task Force's purpose is to ``explore methods to 
improve biosafety oversight in the United States to include a review of 
mechanisms by which the Federal Government can ensure safe working 
conditions in laboratories handling infectious agents.'' This public 
consultation meeting will allow the Task Force to obtain individual 
input from members of the public on several aspects of biosafety and 
biocontainment oversight in the U.S. The meeting's dialogue will focus 
on a series of questions on which the U.S. Government would 
specifically like to solicit comment. These questions concern such 
matters as the identification of gaps in the current oversight 
framework and options for improvement, including how to optimize 
biosafety and biocontainment oversight while simultaneously protecting 
laboratory workers, public health, agriculture, and the environment. 
The agenda and questions for discussion will be available prior to the 
meeting at the Web site http://www.hhs.gov/aspr/omsph/
biosafetytaskforce/index.html. All public comments and recommendations 
will be considered by the Task Force.
    Availability of Materials: The agenda and other materials will be 
posted on the Task Force's Web site at http://www.hhs.gov/aspr/omsph/
biosafetytaskforce/index.html prior to the meeting.
    Procedures for Providing Public Input: Public participation in this 
meeting of the Task Force is encouraged. Interested members of the 
public may attend the meeting in person or participate by public 
teleconference. Any member of the public wishing to obtain information 
regarding participation by teleconference should consult the Web site: 
http://www.hhs.gov/aspr/omsph/biosafetytaskforce/index.html or contact 
CAPT Theresa Lawrence (preferably by e-mail) for more information. 
Interested members of the public may submit relevant written or oral 
information for the Task Force to consider. Oral and written 
information that is submitted may be made be available to the public; 
therefore, we request that statements do not include private or 
proprietary information. Oral Statements: Thirty minutes will be 
available each day of the meeting for public comment. In general, each 
speaker (or group of speakers) requesting an oral

[[Page 71655]]

presentation will be limited to three minutes. To be placed on the 
public speaker list, interested parties should contact CAPT Theresa 
Lawrence in writing (preferably via e-mail), by November 28, 2008. 
Written Statements: In general, individuals or groups may file written 
comments with the Task Force. All written comments must be received 
prior to December 12, 2008 and should be sent to CAPT Theresa Lawrence 
(preferably by e-mail with ``Task Force Public Comment'' as the subject 
line). Individuals needing special assistance should notify CAPT 
Theresa Lawrence (preferably by e-mail) by November 28, 2008.

    Dated:November 18, 2008.
RADM William C. Vanderwagen,
Assistant Secretary for Preparedness and Response, U.S. Department of 
Health and Human Services.
[FR Doc. E8-28013 Filed 11-24-08; 8:45 am]
BILLING CODE 4150-37-P